About Amy Liao
Amy Liao is a board member at seqWell.
Amy Liao first appears on SEC filings in 2023.
Experience
This experience comes from Amy Liao's profile and from SEC filings. For roles taken from filings, the years are when the filings name Amy Liao in the role, so the role may have started earlier or lasted longer.
CI
CourageAS Biotherapeutics, Inc. Current
Chief Executive Officer
2024 – Present
seqWell Inc. Current
Board Member
2022 – Present · Beverly, MA
DNA sequencing preparation kits for research laboratories.
CO
Couragene Current
Co-Founder, Chief Executive Officer
2022 – Present
AH
Admera Health Current
Board Member
2014 – Present
LG
Launchpad Venture Group
Member
2022 – 2023
AS
Azenta Life Sciences
President, Brooks Life Sciences Services [Now Azenta]
2018 – 2021
GA
GENEWIZ [now Azenta]
Co-Founder, CEO
1999 – 2018
Key Colleagues at Startups
The people Amy Liao works with at each company, as listed on that company's latest Form D.
seqWell Inc. · Form D, Sep 10, 2026
DC
Daniel Calvo
Chief Executive Officer and director
AP
Anup Parikh
Board Member
TG
Thomas Grant
Chief Financial Officer
PM
Paul McEwan
Chairman of the Board
MF
Michael Finney
Board Member
JM
Joseph Mellor
Chief Scientific Officer and Co-Founder, director
CS
Chad Souvignier
Board Member